02.05.2024

Welcome, Maik!

Maik Wolfram-Schauerte started on the 01.05.2024 in our group as a Post-Doc in cooperation with Boehringer Ingelheim to work on hybrid transcriptomics machine learning models for drug discovery.

We welcome Maik Wolfram-Schauerte to our team! Maik started on the 01.05.2024 in our group as a Post-Doc in cooperation with Boehringer Ingelheim to work on hybrid transcriptomics machine learning models for drug discovery. Maik has a background in biochemistry and biotechnology and is finishing his PhD in bacterial epitranscriptomics at the Max Planck Institute for Terrestrial Microbiology. Maik has a key interest in innovative technologies and transformative research with particular interest in transcriptomics and machine learning.